共 62 条
[1]
Tiberi S(2022)Drug resistant TB–latest developments in epidemiology, diagnostics and management Int J Infect Dis 124 S20-S5
[2]
Utjesanovic N(2022)Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis PLoS ONE 17 e0270003-13
[3]
Galvin J(2021)HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis BMC Infect Dis 21 1-137
[4]
Centis R(2021)Prevalence of latent tuberculosis infection among health workers in Afghanistan: a cross-sectional study PLoS ONE 16 e0252307-62
[5]
D’Ambrosio L(2020)Prevalence of multi-drug resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa–a high tuberculosis endemic area of Pakistan Pol J Microbiol 69 133-13
[6]
van den Boom M(2012)Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction Brazilian J Infect Dis 16 57-1801
[7]
Xi Y(2019)Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB Eur J Med Res 24 1-66
[8]
Zhang W(2015)WHO’s new end TB strategy The Lancet 385 1799-e34
[9]
Qiao R-J(2022)TB elimination program (NTEP): at a glance J Association Chest Physicians 10 55-606
[10]
Tang J(2011)Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran Am J Ther 18 e29-103